SCHEMBL19689804

SCHEMBL19689804

O=C(Nc1cccc(OCCO)n1)N1c2nc(-c3cccc(C(F)(F)F)c3)c(Cl)cc2N2CC[C@H]1C2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ KIF18A Q8NI77 8/20 0.36
▸ LIPG Q9Y5X9 1/20 0.35
▸ NPY2R P49146 1/20 0.35
▸ GPR52 Q9Y2T5 1/20 0.35
▸ TRPV4 Q9HBA0 2/20 0.34
▸ PHGDH O43175 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ RPS6KA5 O75582 1/20 0.34
▸ RPS6KA4 O75676 1/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ RPS6KA3 P51812 1/20 0.34
▸ RPS6KA2 Q15349 1/20 0.34
▸ RPS6KA1 Q15418 1/20 0.34
▸ RPS6KB2 Q9UBS0 1/20 0.34
▸ RPS6KA6 Q9UK32 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17768001 0.97 ALDH1A1 (0.36) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL17768197 0.93 KIF18A (0.39) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL17778225 0.92 ALDH1A1 (0.37) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL19689672 0.91 ALDH1A1 (0.35) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL19706612 0.91 ALDH1A1 (0.35) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL17778774 0.91 NPY2R (0.36) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL17768204 0.91 NPY2R (0.36) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL17778530 0.91 ALDH1A1 (0.35) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
SCHEMBL19689671 0.91 ALDH1A1 (0.35) ALDH1A1KDM4ECYP2C9HPGDCYP2C19
Hydrochloric Acid SCHEMBL19689761 0.91 ALDH1A1 (0.34) ALDH1A1KDM4ECYP2C9HPGDCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170355705-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2017-12-14 — — US disclosed
US-20170355705-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2017-12-14 — — US disclosed
US-20170355705-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2017-12-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170355705-A1 SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS SIRT1, SIRT3, SIRT2 ALDH1A1 993/4885KDM4E 1355/4885CYP2C9 1342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback